News and events

News stories

News related to gene therapy at the ±¬ÁÏTV and related events.
Process development team and the bronze LEAF certificate

Bronze LEAF Accreditation

The GTIMC process development lab has achieved bronze accreditation under the laboratory efficiency assessment framework (LEAF)
A gloved hand pointing at a screen showing research data

The race to ‘Decode ALS’: Sheffield scientists awarded global prize for breakthrough AI drug discovery

±¬ÁÏTV has been named a winner of the Longitude Prize on ALS, cementing its reputation as a world leader in the fight against Motor Neuron Disease
architectural drawing of the GTIMC facility. View from outside.

BSGCT Annual Conference 2026

Join us at the BSGCT Annual Conference in Newcastle 15th - 17th April to discuss the latest advancements in gene therapy.
A glowing digital representation of a DNA double helix structure, composed of particles and light effects, symbolizing genetics, biotechnology, and molecular science.

DNA shape explains crucial gene-therapy challenges, study finds

A mystery surrounding why powerful gene-editing technology that has driven major advances in medicine over the past decade can sometimes make mistakes, has been solved with the help of scientists from the ±¬ÁÏTV.
Image of motor neurones

Sheffield scientist awarded prestigious prize for ground breaking MND research

Dr Johnathan Cooper-Knock from the ±¬ÁÏTV is one of eight outstanding scientists nationwide to receive the 2025 Lister Award in recognition of his pioneering MND research.
Neuron cells system - 3d rendered image of Neuron cell network on black background

University spinout company awarded £2.3 million to develop breakthrough therapies that address underlying causes of MND

Crucible Therapeutics and ±¬ÁÏTV secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND).
Visual representation Runway Park

Runway Park: A vision for innovation-led growth takes flight

A transformative ±¬ÁÏTV development designed to attract investment, create high-quality jobs and accelerate economic growth unveils its new look as Runway Park is officially launched to industry.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
illustration of DNA molecule

Sheffield researchers help discover previously unidentified genes linked to rare diseases

A landmark study has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of kidney disease and diabetes.